Phibro Animal Health - Class A opened higher at $35.19, compared with its previous close of $35.15. In the last trading session, the stock traded between $34.79 and $35.51. It showed an upward intraday trend.
An investment of $100 made 5 years ago in Phibro Animal Health - Class A is now worth
$ 155.80
Giving a profit of
$ 55.80 (55.80%)
Note: Past profits do not guarantee future returns.
Rating from 2 Analysts
Today's Change
+$0.30 (+0.84%)
Day High
$35.51
Day Low
$34.79
Day Open
$35.19
Prev Close
$35.15
Volume
86,322
1W Return
-10.30%
1M Return
-5.42%
3M Return
4.03%
6M Return
-2.41%
1Y Return
-21.81%
Market Cap ($ Mn)
748
PE Ratio
15.53
PB Ratio
3.97
PEG Ratio
1.23
ROE
18.37%
ROCE
10.41%
EPS (TTM)
$0.73
1 Week
-10.30%
1 Month
-5.42%
3 Months
4.03%
6 Months
-2.41%
9 Months
-31.20%
Phibro Animal Health FY27 guidance: Sales $1.550B-$1.600B, EPS $3.41-$3.59
Adjusted EPS guidance for FY2027 affirmed at $3.41-$3.59, compared to $3.50 analyst estimate. Sales outlook maintained at $1.550 billion-$1.600 billion, versus $1.578 billion analyst estimate. Guidance ranges indicate alignment with market expectations for profitability and slight conservatism on revenue.
8 days agoPhibro Animal Health to address investors at Morgan Stanley conference
Phibro Animal Health to present at Morgan Stanley Annual Global Healthcare Conference. CEO Daniel Bendheim, COO Larry Miller, and CFO Glenn David to lead the session. Presentation scheduled for September 15, 2026, at 1:05 pm ET in New York. Live audio and replay available on the company's Investor Relations website.
2mo agoPhibro Animal Health Q4 adj EPS $0.85 beats estimate
Phibro Animal Health Q4 FY26 adj EPS of $0.85 beat the $0.71 estimate. Full-year net sales rose 17% to $1.5 billion, driven by MFA acquisition. FY27 guidance assumes minimal virginiamycin sales in Brazil. Chicago Heights facility closure aims for $15M-$20M annual savings from FY28.
2mo agoPhibro Animal Health Corp to close Chicago Heights facility in summer 2027
Phibro Animal Health Corp will close its Chicago Heights facility in summer 2027. Approximately 100 employees are affected by the strategic consolidation. Production shifts to other Phibro-owned and third-party contract manufacturers. Decision follows a review of the manufacturing network post-MFA acquisition in 2024.
2mo agoPhibro Animal Health sets FY27 adj EPS $3.41-$3.59, beats est
Phibro Animal Health forecasts FY27 adjusted EPS of $3.41-$3.59. Analyst consensus for adjusted EPS was $3.34. Revenue guidance set at $1.550B-$1.600B. Sales estimate from analysts was $1.548B.
2mo agoPhibro Animal Health to report Q4 FY26 results on August 26
Phibro Animal Health Corporation will release Q4 and FY26 results on August 26, 2026. A management conference call follows on August 27 at 9:00 am ET. Investors can join via webcast or phone using conference ID 3927884.
2mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,437.29 | +0.35% | $13,52,123.38M | 39.43 | |
| $280.41 | -0.13% | $6,75,033.80M | 31.06 | |
| $294.98 | +0.37% | $5,21,411.37M | 72.17 | |
| $147.18 | -0.59% | $3,62,834.91M | 117.74 | |
| $160.32 | -1.80% | $3,26,222.34M | 23.23 | |
| $185.48 | -0.69% | $2,87,691.54M | 24.32 | |
| $468.11 | +0.62% | $2,53,205.85M | 26.86 | |
| $169.73 | -0.67% | $2,10,522.74M | - | |
| $29.45 | +0.31% | $1,67,860.70M | 36.79 | |
| $41.09 | +0.96% | $1,39,300.36M | 11.15 | |
| $62.91 | +0.18% | $1,28,593.45M | 14.67 | |
| $48.43 | +0.41% | $1,16,984.89M | 23.63 |
An investment of $100 made 5 years ago in Phibro Animal Health - Class A is now worth
$ 155.80
Giving a profit of
$ 55.80 (55.80%)
Note: Past profits do not guarantee future returns.
